Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-09-02

FDA Approved: INTUNIV — Original Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

FDA approved Intuniv (guanfacine) Extended-Release under Takeda's Original Application, establishing this product for the treatment of attention-deficit/hyperac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Intuniv (guanfacine hydrochloride)

Snippet

ORIG AP for INTUNIV (GUANFACINE)